Solid IO
Founded 2025 · 13 employees on LinkedIn · 5 known investors
Find your way into Solid IO
Sign up to see every warm intro you have to Solid IO
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solid IO team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solid IO develops a tumor-on-chip platform using organ-on-chip technology and AI to model patient-specific tumor microenvironments for oncology and immunotherapy research. The platform enables pharmaceutical companies, biotech firms, and cancer clinics to predict treatment responses, accelerate drug development, and support precision medicine in cancer care.
Investors · 5
How we know: the company's own site · Not right? Tell us
How we know: BSV Ventures's portfolio page · funding news · paaomasijoittajat.fi · Not right? Tell us
How we know: Leo Capital Ventures's portfolio page · Not right? Tell us
How we know: funding news · paaomasijoittajat.fi · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountfirst funding roundFeb 2025 · 2 sources
Nordic Science Investments (lead), BSV Ventures, Helsinki University Funds
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Solid IO do?
- Solid IO develops a tumor-on-chip platform using organ-on-chip technology and AI to model patient-specific tumor microenvironments for oncology and immunotherapy research. The platform enables pharmaceutical companies, biotech firms, and cancer clinics to predict treatment responses, accelerate drug development, and support precision medicine in cancer care.
- Who are Solid IO's investors?
- Solid IO's investors include Leo Capital, BSV Ventures, Leo Capital Ventures, Nordic Science Investments.



